FDA grants accelerated approval for Alzheimer's drug
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA approves new drug treatment for chronic weight management, first since 2014
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA authorizes additional monoclonal antibody for treatment of COVID-19
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA authorizes Pfizer-BioNTech COVID-19 vaccine for emergency use in adolescents in another important action in fight against pandemic
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA and CDC lift recommended pause on Johnson & Johnson (Janssen) COVID-19 vaccine use following thorough safety review
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA revokes emergency use authorization for monoclonal antibody Bamlanivimab
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
Joint CDC and FDA statement on Johnson & Johnson COVID-19 vaccine
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
More Pharma News ...
- AstraZeneca's COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets
- Increase in vaccine manufacturing capacity and supply for COVID-19 vaccines from AstraZeneca, BioNTech/Pfizer and Moderna
- EMA's safety committee continues investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events
- EMA recommends COVID-19 Vaccine Janssen for authorisation in the EU
- EMA starts rolling review of the Sputnik V COVID-19 vaccine
- FDA issues Emergency Use Authorization for third COVID-19 vaccine
- FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19